Open AccessLINX® reflux management system to bridge the “treatment gap” in gastroesophageal reflux disease: A systematic review of 35 studies
Author(s) -
Dimitrios Schizas,
Aikaterini Mastoraki,
Eleni Papoutsi,
Vassilis G. Giannakoulis,
Prodromos Kanavidis,
Diamantis I. Tsilimigras,
Dimitrios Ntourakis,
Orestis Lyros,
Theodore Liakakos,
Demetrios Moris
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i2.294
Subject(s) - medicine , gerd , dysphagia , reflux , gold standard (test) , disease , gastroenterology , meta analysis , systematic review , omeprazole , surgery , medline , political science , law
Gastroesophageal reflux disease (GERD) occurs when the reflux of stomach contents causes troublesome symptoms and/or complications. When medical therapy is insufficient, surgical therapy is indicated and, until now, Laparoscopic fundoplication (LF) constitutes the gold-standard method. However, magnetic sphincter augmentation (MSA) using the LINX ® Reflux Management System has recently emerged and disputes the standard therapeutic approach.